microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia.

Daniela Asslaber; Josefina D Piñón; Irina Seyfried; Petra Desch; Markus Stöcher; Inge Tinhofer; Alexander Egle; Olaf Merkel; Richard Greil

doi:10.1182/blood-2009-07-234823

microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia.

Daniela Asslaber (First author), Josefina D Piñón (Co-author), Irina Seyfried, Petra Desch, Markus Stöcher, Inge Tinhofer, Alexander Egle (Co-author), Olaf Merkel, Richard Greil (Last author)

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article › peer-review

85 Citations (Web of Science)

Original language	English
Pages (from-to)	4191-4197
Journal	BLOOD
Volume	115
Issue number	21
DOIs	https://doi.org/10.1182/blood-2009-07-234823
Publication status	Published - 2010

Keywords

SINGLE NUCLEOTIDE POLYMORPHISM
REDUCES TUMOR-GROWTH
MUTATION STATUS
TRANSGENIC MOUSE
DOWN-REGULATION
POOR-PROGNOSIS
CLL PATIENTS
LUNG-CANCER
B-CLL
MIR-34A

Access to Document

10.1182/blood-2009-07-234823

Cite this

Asslaber, D., Piñón, J. D., Seyfried, I., Desch, P., Stöcher, M., Tinhofer, I., Egle, A., Merkel, O., & Greil, R. (2010). microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia. BLOOD , 115(21), 4191-4197. https://doi.org/10.1182/blood-2009-07-234823

Asslaber, Daniela ; Piñón, Josefina D ; Seyfried, Irina et al. / microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia. In: BLOOD 2010 ; Vol. 115, No. 21. pp. 4191-4197.

@article{f7b8444c37fa41f48b5c3c65d07ee184,

title = "microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia.",

keywords = "SINGLE NUCLEOTIDE POLYMORPHISM, REDUCES TUMOR-GROWTH, MUTATION STATUS, TRANSGENIC MOUSE, DOWN-REGULATION, POOR-PROGNOSIS, CLL PATIENTS, LUNG-CANCER, B-CLL, MIR-34A",

author = "Daniela Asslaber and Pi{\~n}{\'o}n, {Josefina D} and Irina Seyfried and Petra Desch and Markus St{\"o}cher and Inge Tinhofer and Alexander Egle and Olaf Merkel and Richard Greil",

year = "2010",

doi = "10.1182/blood-2009-07-234823",

language = "English",

volume = "115",

pages = "4191--4197",

journal = "BLOOD ",

issn = "0006-4971",

publisher = "American Society of Hematology ",

number = "21",

}

Asslaber, D, Piñón, JD, Seyfried, I, Desch, P, Stöcher, M, Tinhofer, I, Egle, A, Merkel, O & Greil, R 2010, 'microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia.', BLOOD , vol. 115, no. 21, pp. 4191-4197. https://doi.org/10.1182/blood-2009-07-234823

microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia. / Asslaber, Daniela (First author); Piñón, Josefina D (Co-author); Seyfried, Irina et al.
In: BLOOD , Vol. 115, No. 21, 2010, p. 4191-4197.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia.

AU - Asslaber, Daniela

AU - Piñón, Josefina D

AU - Seyfried, Irina

AU - Desch, Petra

AU - Stöcher, Markus

AU - Tinhofer, Inge

AU - Egle, Alexander

AU - Merkel, Olaf

AU - Greil, Richard

PY - 2010

Y1 - 2010

KW - SINGLE NUCLEOTIDE POLYMORPHISM

KW - REDUCES TUMOR-GROWTH

KW - MUTATION STATUS

KW - TRANSGENIC MOUSE

KW - DOWN-REGULATION

KW - POOR-PROGNOSIS

KW - CLL PATIENTS

KW - LUNG-CANCER

KW - B-CLL

KW - MIR-34A

U2 - 10.1182/blood-2009-07-234823

DO - 10.1182/blood-2009-07-234823

M3 - Original Article

C2 - 20089965

SN - 0006-4971

VL - 115

SP - 4191

EP - 4197

JO - BLOOD

JF - BLOOD

IS - 21

ER -

Asslaber D, Piñón JD, Seyfried I, Desch P, Stöcher M, Tinhofer I et al. microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia. BLOOD . 2010;115(21):4191-4197. doi: 10.1182/blood-2009-07-234823